Center-Authored Papers

Filters: Author is Gooley, Ted A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2012
Gerds AT, Gooley TA, Estey EH, Appelbaum FR, Deeg HJ, Scott BL.  2012.  Pretransplantation Therapy with Azacitidine vs Induction Chemotherapy and Posttransplantation Outcome in Patients with MDS.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(8):1211-8. Abstract
Venstrom JM, Pittari G, Gooley TA, Chewning JH, Spellman S, Haagenson M, Gallagher MM, Malkki M, Petersdorf E, Dupont B et al..  2012.  HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.. The New England journal of medicine. 367(9):805-16. Abstract
Scott BL, Gooley TA, Sorror ML, Rezvani AR, Linenberger ML, Grim J, Sandmaier BM, Myerson D, Chauncey TR, Storb R et al..  2012.  The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantation.. Blood. 119(11):2657-2664. Abstract
Newell LF, Milano F, Nicoud IB, Pereira S, Gooley TA, Heimfeld S, Delaney C.  2012.  Early CD3 Peripheral Blood Chimerism Predicts the Long-Term Engrafting Unit Following Myeloablative Double-Cord Blood Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(8):1243-9. Abstract
2013
Budde LE, Zhang MM, Shustov AR, Pagel JM, Gooley TA, Oliveira GR, Chen TL, Knudsen NL, Roden JE, Kammerer BE et al..  2013.  A phase I study of pulse high-dose vorinostat (V) plus rituximab (R), ifosphamide, carboplatin, and etoposide (ICE) in patients with relapsed lymphoma.. British journal of haematology. 161(2):183-91. Abstract
Gerds AT, Gooley TA, Wilson WA, Deeg HJ.  2013.  Components of the revised International Prognostic Scoring System and outcome after hematopoietic cell transplantation for myelodysplastic syndrome.. Blood. 121(19):4007-8.
Mawad R, Gooley TA, Sandhu V, Lionberger J, Scott B, Sandmaier BM, O'Donnell P, Becker PS, Petersdorf S, Dorcy KS et al..  2013.  Frequency of allogeneic hematopoietic cell transplantation among patients with high- or intermediate-risk acute myeloid leukemia in first complete remission.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(31):3883-8. Abstract
2014
Gopal AK, Gooley TA, Rajendran JG, Pagel JM, Fisher DR, Maloney DG, Appelbaum FR, Cassaday RD, Shields A, Press OW.  2014.  Myeloablative I-131-Tositumomab with Escalating Doses of Fludarabine and Autologous Hematopoietic Transplantation for Adults Aged ≥ 60 Years with B-Cell Lymphoma.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 20(6):770-5. Abstract
Mawad R, Gooley TA, Rajendran JG, Fisher DR, Gopal AK, Shields AT, Sandmaier BM, Sorror ML, Deeg HJ, Storb R et al..  2014.  Radiolabeled Anti-CD45 Antibody with Reduced-Intensity Conditioning and Allogeneic Transplantation for Younger Patients with Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 20(9):1363-8. Abstract
Ma KK, McDougall JA, Preusse CJ, Gooley TA, Li CI, Gadi VK, Gammill HS.  2014.  Preeclampsia and Breast Cancer Risk According to Tumor Biology. Reproductive Sciences. 21:285a-285a. Abstract
Bar M, Wood BL, Radich JP, Doney KC, Woolfrey AE, Delaney C, Appelbaum FR, Gooley TA.  2014.  Impact of minimal residual disease, detected by flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia.. Leukemia research and treatment. 2014:421723. Abstract
2015
Bleakley M, Heimfeld S, Loeb KR, Jones LA, Chaney C, Seropian S, Gooley TA, Sommermeyer F, Riddell SR, Shlomchik WD.  2015.  Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts.. The Journal of clinical investigation. 125(7):2677-89. Abstract
Adult
Keeney GE, Gooley TA, Pham RN, Press OW, Pagel JM, Petersdorf SH, Maloney DG, Bensinger WI, Holmberg L, Gopal AK.  2007.  The pretransplant Follicular Lymphoma International Prognostic Index is associated with survival of follicular lymphoma patients undergoing autologous hematopoietic stem cell transplantation.. Leukemia & lymphoma. 48(10):1961-7. Abstract
Aged
Keeney GE, Gooley TA, Pham RN, Press OW, Pagel JM, Petersdorf SH, Maloney DG, Bensinger WI, Holmberg L, Gopal AK.  2007.  The pretransplant Follicular Lymphoma International Prognostic Index is associated with survival of follicular lymphoma patients undergoing autologous hematopoietic stem cell transplantation.. Leukemia & lymphoma. 48(10):1961-7. Abstract
Gopal AK, Rajendran JG, Gooley TA, Pagel JM, Fisher DR, Petersdorf SH, Maloney DG, Eary JF, Appelbaum FR, Press OW.  2007.  High-dose [131I]tositumomab (anti-CD20) radioimmunotherapy and autologous hematopoietic stem-cell transplantation for adults > or = 60 years old with relapsed or refractory B-cell lymphoma.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(11):1396-402. Abstract
Venstrom JM, Pittari G, Gooley TA, Chewning JH, Spellman S, Haagenson M, Gallagher MM, Malkki M, Petersdorf E, Dupont B et al..  2012.  HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.. The New England journal of medicine. 367(9):805-16. Abstract
Algorithms
Keeney GE, Gooley TA, Pham RN, Press OW, Pagel JM, Petersdorf SH, Maloney DG, Bensinger WI, Holmberg L, Gopal AK.  2007.  The pretransplant Follicular Lymphoma International Prognostic Index is associated with survival of follicular lymphoma patients undergoing autologous hematopoietic stem cell transplantation.. Leukemia & lymphoma. 48(10):1961-7. Abstract
Antibodies, Monoclonal
Gopal AK, Rajendran JG, Gooley TA, Pagel JM, Fisher DR, Petersdorf SH, Maloney DG, Eary JF, Appelbaum FR, Press OW.  2007.  High-dose [131I]tositumomab (anti-CD20) radioimmunotherapy and autologous hematopoietic stem-cell transplantation for adults > or = 60 years old with relapsed or refractory B-cell lymphoma.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(11):1396-402. Abstract
Antigens, CD20
Gopal AK, Rajendran JG, Gooley TA, Pagel JM, Fisher DR, Petersdorf SH, Maloney DG, Eary JF, Appelbaum FR, Press OW.  2007.  High-dose [131I]tositumomab (anti-CD20) radioimmunotherapy and autologous hematopoietic stem-cell transplantation for adults > or = 60 years old with relapsed or refractory B-cell lymphoma.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(11):1396-402. Abstract
Antineoplastic Agents
Gopal AK, Rajendran JG, Gooley TA, Pagel JM, Fisher DR, Petersdorf SH, Maloney DG, Eary JF, Appelbaum FR, Press OW.  2007.  High-dose [131I]tositumomab (anti-CD20) radioimmunotherapy and autologous hematopoietic stem-cell transplantation for adults > or = 60 years old with relapsed or refractory B-cell lymphoma.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(11):1396-402. Abstract
Bioinformatics Core Facility
Au BKC, Gooley TA, Armand P, Fang M, Madtes DK, Sorror ML, Boeckh MJ, Gibson CJ, Deeg HJ, Storb R et al..  2015.  Reevaluation of the pretransplant assessment of mortality score after allogeneic hematopoietic transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(5):848-54. Abstract
Biologics Production Core Facility
O'Steen S, Green DJ, Gopal AK, Orozko JJ, Kenoyer AL, Lin Y, Wilber SD, Hamlin DK, Fisher DR, Hylarides MD et al..  2017.  Venetoclax Synergizes with Radiotherapy for Treatment of B cell Lymphomas.. Cancer research. 77(14):3885-3893. Abstract
Mawad R, Gooley TA, Rajendran JG, Fisher DR, Gopal AK, Shields AT, Sandmaier BM, Sorror ML, Deeg HJ, Storb R et al..  2014.  Radiolabeled Anti-CD45 Antibody with Reduced-Intensity Conditioning and Allogeneic Transplantation for Younger Patients with Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 20(9):1363-8. Abstract
Gopal AK, Gooley TA, Rajendran JG, Pagel JM, Fisher DR, Maloney DG, Appelbaum FR, Cassaday RD, Shields A, Press OW.  2014.  Myeloablative I-131-Tositumomab with Escalating Doses of Fludarabine and Autologous Hematopoietic Transplantation for Adults Aged ≥ 60 Years with B-Cell Lymphoma.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 20(6):770-5. Abstract
Orozco JJ, Balkin ER, Gooley TA, Kenoyer A, Hamlin DK, Wilbur SD, Fisher DR, Hylarides MD, Shadman M, Green DJ et al..  2014.  Anti-CD45 radioimmunotherapy with 90Y but not 177Lu is effective treatment in a syngeneic murine leukemia model.. PloS one. 9(12):e113601. Abstract